Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange Detected- Version history updated: added revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check18 days agoChange DetectedFooter/revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as Revision: v3.4.1.SummaryDifference0.5%

- Check54 days agoChange DetectedAdded a funding/operational status notice at the top of the page and updated the revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' field to improve readability and data transparency. The previous 'Last Update Submitted that met QC Criteria' label and the 'No FEAR Act data' text were adjusted, and the page includes a new revision tag 'v3.4.0'.SummaryDifference0.3%

- Check75 days agoChange DetectedSite revision label updated to Revision: v3.3.4; the previous Revision: v3.3.3 label was removed.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.